199 related articles for article (PubMed ID: 22272725)
1. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance.
Erkan M; Reiser-Erkan C; Michalski CW; Kong B; Esposito I; Friess H; Kleeff J
Curr Mol Med; 2012 Mar; 12(3):288-303. PubMed ID: 22272725
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and progression of pancreatic cancer.
Erkan M; Reiser-Erkan C; Michalski CW; Kleeff J
Exp Oncol; 2010 Sep; 32(3):128-31. PubMed ID: 21403605
[TBL] [Abstract][Full Text] [Related]
3. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.
Erkan M; Hausmann S; Michalski CW; Fingerle AA; Dobritz M; Kleeff J; Friess H
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):454-67. PubMed ID: 22710569
[TBL] [Abstract][Full Text] [Related]
4. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: Stroma and its current and emerging targeted therapies.
Kota J; Hancock J; Kwon J; Korc M
Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284
[TBL] [Abstract][Full Text] [Related]
7. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
8. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
[TBL] [Abstract][Full Text] [Related]
9. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
Wong KM; Horton KJ; Coveler AL; Hingorani SR; Harris WP
Curr Oncol Rep; 2017 Jul; 19(7):47. PubMed ID: 28589527
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
12. Assessment of different 3D culture systems to study tumor phenotype and chemosensitivity in pancreatic ductal adenocarcinoma.
Zeeberg K; Cardone RA; Greco MR; Saccomano M; Nøhr-Nielsen A; Alves F; Pedersen SF; Reshkin SJ
Int J Oncol; 2016 Jul; 49(1):243-52. PubMed ID: 27177201
[TBL] [Abstract][Full Text] [Related]
13. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
[TBL] [Abstract][Full Text] [Related]
14. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
15. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
Topalovski M; Brekken RA
Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic stellate cell: Pandora's box for pancreatic disease biology.
Bynigeri RR; Jakkampudi A; Jangala R; Subramanyam C; Sasikala M; Rao GV; Reddy DN; Talukdar R
World J Gastroenterol; 2017 Jan; 23(3):382-405. PubMed ID: 28210075
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer stroma: controversies and current insights.
Ansari D; Carvajo M; Bauden M; Andersson R
Scand J Gastroenterol; 2017; 52(6-7):641-646. PubMed ID: 28276831
[TBL] [Abstract][Full Text] [Related]
18. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
Bijlsma MF; van Laarhoven HW
Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
[TBL] [Abstract][Full Text] [Related]
19. Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.
Whatcott CJ; Diep CH; Jiang P; Watanabe A; LoBello J; Sima C; Hostetter G; Shepard HM; Von Hoff DD; Han H
Clin Cancer Res; 2015 Aug; 21(15):3561-8. PubMed ID: 25695692
[TBL] [Abstract][Full Text] [Related]
20. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.
Houg DS; Bijlsma MF
Mol Cancer; 2018 Jun; 17(1):95. PubMed ID: 29903049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
